Some researchers have suggested that although patients with underlying diseases are more susceptible to SARS-CoV-2 infection, patients suffering from head and neck cancer or lung cancer have reduced expression of TMPRSS2 in the body (Sacconi et al., 2020), which makes these patients less susceptible to SARS-CoV-2. This evidence concerns the gene TMPRSS2 and lung cancer.